Do you want BuboFlash to help you learning these things? Or do you want to add or correct something? Click here to log in or create user.

Tolvaptan, a vasopressin receptor antagonist, results in the excretion of electrolyte free water and is effective in raising the serum sodium in patients with SIADH. It should be used with caution in the treatment of severe, symptomatic hyponatremia,
If you want to change selection, open document below and click on "Move attachment"


owner: ELBOMBARDO - (no access) - MKSAP_17.pdf, p3514


statusnot read reprioritisations
last reprioritisation on suggested re-reading day
started reading on finished reading on



Do you want to join discussion? Click here to log in or create user.